Health Catalyst HCAT 深 滬
等待開盤 09-24 09:30:00 美东时间
1.72
-0.170
-8.99%
華盛通- 最 高1.87
- 今 開1.87
- 成交量 19.80万股
- 最 低 1.72
- 昨 收 1.89
- 總市值 1.29亿
- 52周最高 3.615
- 市盈率 靜 --
- 換手率 0.26%
- 52周最低 0.9551
- 委 比 23.30%
- 總股本 7525.64万
- 歷史最高 59.50
- 量 比 0.41
- 振 幅 7.94%
- 歷史最低 0.9551
- 每 手 1
- 風險率 0.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript
Health Catalyst (NASDAQ:HCAT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. Access the full call...
09-18 18:47
Health Catalyst Adds Tami Reller to Board for Growth
The latest announcement is out from Health Catalyst ( ($HCAT) ). On September 1...
09-15 05:50
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Health Catalyst, Inc. announced on September 14, 2026, that it granted 2,747,385 restricted stock units (RSUs) to Simeon Kohl, its newly appointed CEO and President, under the 2026 Employment Inducement Incentive Plan. Of the RSUs, 915,975 will vest on September 14, 2027, with the remainder vesting in eight equal quarterly installments, contingent on continued employment. Kohl also acquired 59,000 shares of the company's common stock through open...
09-14 22:32
Health Catalyst appoints Simeon Kohl as new CEO
Health Catalyst ( ($HCAT) ) has issued an announcement. On September 4, 2026, H...
09-08 20:29
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
Health Catalyst appoints Simeon Kohl as CEO and President, effective Sept. 14, 2026. Kohl, with over 20 years in healthcare leadership, previously led Performant Healthcare through transformation and its $670 million sale. Current CEO Ben Albert transitions to Chief Business Officer, stepping down from the Board on Sept. 13. Albert, who strengthened the company’s focus on AI-driven solutions and divested Vitalware, praised Kohl’s experience and v...
09-08 12:00
Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst, Inc. announced that its senior management will participate in the 2026 Wells Fargo Healthcare Conference in Boston on September 9-10, 2026. Health Catalyst is a healthcare intelligence company focused on improving health systems' performance through data-driven solutions and AI technology.
08-31 20:05
美股大行评级 | 罗斯百货、迪尔股份获多家大行上调目标价；沃尔玛、Advance遭多家大行下调目标价
今日重点评级关注：摩根士丹利：维持Ultragenyx Pharmaceutical"超配"评级，目标价从67美元升至74美元；Truist Securities：维持Solid Biosciences"买入"评级，目标价从16美元升至20美元
08-24 16:40
This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Quinn Fredrickson downgraded Teradyne Inc (NASDAQ:TER) from Outperform to Neutral a...
08-21 23:08
Canaccord Genuity Downgrades Health Catalyst to Hold, Lowers Price Target to $1.8
Canaccord Genuity analyst Richard Close downgrades Health Catalyst (NASDAQ:HCAT) from Buy to Hold and lowers the price target from $3 to $1.8.
08-21 20:42
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
